PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia

Summary

The purpose of this study is to evaluate the efficacy of paliperidone extended-release (ER) in participants with schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self).

Timeline

Start

2008-02

Primary completion

2010-07

Completion

2010-07

Drugs

Indications